Cargando…

Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer

BACKGROUND: Low expression of NCALD(neurocalcin delta) in peripheral blood of ovarian cancer patients predicts poor prognosis. However, the molecular mechanism of NCALD in ovarian cancer and its relationship with chemotherapy outcomes is unclear. The aim of this study was to investigate the potentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Li-yuan, Li, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106630/ https://www.ncbi.nlm.nih.gov/pubmed/32228639 http://dx.doi.org/10.1186/s13048-020-00635-6

Ejemplares similares

High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia
por: Song, Ying, et al.
Publicado: (2019)

Clinicopathological and prognostic significance of NCALD protein expression in lung adenocarcinoma
por: Chen, Yi, et al.
Publicado: (2019)

Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer
por: Wang, Lishuang, et al.
Publicado: (2015)

Expression of resistance gene and prognosis of chemotherapy in primary epithelial ovarian cancer
por: Yang, Fengmei, et al.
Publicado: (2018)

Long-Term SMN- and Ncald-ASO Combinatorial Therapy in SMA Mice and NCALD-ASO Treatment in hiPSC-Derived Motor Neurons Show Protective Effects
por: Muiños-Bühl, Anixa, et al.
Publicado: (2023)

High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer
por: Han, Gwan Hee, et al.
Publicado: (2023)

Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2021)

High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2015)

Correction: High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis
por: Hou, Minzhi, et al.
Publicado: (2020)

VGLL3 expression is associated with macrophage infiltration and predicts poor prognosis in epithelial ovarian cancer
por: Haque, Razaul, et al.
Publicado: (2023)

Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma
por: Sung, Pi-Lin, et al.
Publicado: (2015)

Whole genome expression profiling of blood cells in ovarian cancer patients -Prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14 genes
por: Isaksson, Helena S., et al.
Publicado: (2014)

Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis
por: Tsofack, Serges P, et al.
Publicado: (2013)

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2017)

Low expression of BMPRIB indicates poor prognosis of breast cancer and is insensitive to taxane-anthracycline chemotherapy
por: Dai, Kun, et al.
Publicado: (2015)

Low FOXJ2 expression is associated with unfavorable postoperative prognosis of patients with epithelial ovarian cancer
por: Li, Yong, et al.
Publicado: (2021)

Low EIF2B5 expression predicts poor prognosis in ovarian cancer
por: Hou, Lin, et al.
Publicado: (2020)

High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer
por: Iwadate, Reiko, et al.
Publicado: (2014)

The HSP70 gene predicts prognosis and response to chemotherapy in epithelial ovarian cancer
por: Li, Xiao-Fei, et al.
Publicado: (2021)

Galectin-3 and β-catenin are associated with a poor prognosis in serous epithelial ovarian cancer
por: Liu, Yunyun, et al.
Publicado: (2018)

Increased expression of plakophilin 3 is associated with poor prognosis in ovarian cancer
por: Qian, Hua, et al.
Publicado: (2019)

High Expression of F-Box Protein 43 Is Associated With Poor Prognosis and Adjuvant Chemotherapy Resistance in Colorectal Cancer
por: Liu, Junyu, et al.
Publicado: (2023)

Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer
por: Ma, Zebiao, et al.
Publicado: (2017)

Low BCL7A expression predicts poor prognosis in ovarian cancer
por: Sun, Ziqian, et al.
Publicado: (2019)

Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer
por: Xu, Tao, et al.
Publicado: (2020)

Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer
por: Choi, Chel Hun, et al.
Publicado: (2018)

High LIN28A and PLK4 co-expression is associated with poor prognosis in epithelial ovarian cancer
por: He, Yao, et al.
Publicado: (2018)

Low expression of Rap1GAP is associated with epithelial-mesenchymal transition (EMT) and poor prognosis in gastric cancer
por: Yang, Ya, et al.
Publicado: (2016)

MYH9 overexpression correlates with clinicopathological parameters and poor prognosis of epithelial ovarian cancer
por: Liu, Longyang, et al.
Publicado: (2019)

Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD
por: Luo, Dan, et al.
Publicado: (2023)

High BMP7 expression is associated with poor prognosis in ovarian cancer
por: Vasan, Richa, et al.
Publicado: (2023)

Overexpression of Notch3 and pS6 Is Associated with Poor Prognosis in Human Ovarian Epithelial Cancer
por: Liu, Zhaoxia, et al.
Publicado: (2016)

Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer
por: Xu, Yunzhao, et al.
Publicado: (2015)

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015)

Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer
por: Kimura, Akiharu, et al.
Publicado: (2016)

Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer
por: Li, Weiping, et al.
Publicado: (2012)

SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma
por: Zhang, Peng-Fei, et al.
Publicado: (2019)

Preoperative albumin-to-fibrinogen ratio predicts chemotherapy resistance and prognosis in patients with advanced epithelial ovarian cancer
por: Yu, Wen, et al.
Publicado: (2019)

Low extracellular lysyl oxidase expression is associated with poor prognosis in patients with prostate cancer
por: Zheng, Wei, et al.
Publicado: (2016)

Overexpression of thymic stromal lymphopoietin is correlated with poor prognosis in epithelial ovarian carcinoma
por: Xu, Lu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6nv62pjb54nue5j6dc9vp5tpal